Genotoxicity of the laxative drug components emodin, aloe-emodin and danthron in mammalian cells: Topoisomerase II mediated?

Mutation Research - Genetic Toxicology

Volumn 371, Issue 3-4, 1996, Pages 165-173

  Müller, Stefan O ^a   Eckert, Inge ^a   Lutz, Werner K ^a   Stopper, Helga ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

1,8 Dihydroxyanthraquinone; Aloe emodin; Comet assay; Danthron; Emodin; Micronucleus; Mouse L5178Y cell; Topoisomerase II

Indexed keywords

ALOE EMODIN; AMSACRINE; DANTRON; DNA TOPOISOMERASE (ATP HYDROLYSING); EMODIN; ETOPOSIDE; LAXATIVE; VINBLASTINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; GENOTOXICITY; LEUKEMIA L 5178 Y; MICRONUCLEUS TEST; MOUSE; MUTAGENICITY; MUTATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0030596126     PISSN: 01651218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1218(96)90105-6     Document Type: Article

References (42)

1. Thomson R.H. III. Recent Advances, Naturally Occurring Quinones. 1968;Chapman and Hall, London.
2. Banthorpe D.V., White J.J. Novel anthraquinones from undifferentiated cell cultures of Galium verum. Phytochemistry. 38:1995;107-111.
3. Von Wright A., Raatikainen O., Taipale H., Kärenlampi S., Mäki-Paakkanen J. Directly acting geno- and cytotoxic agents from a wild mushroom Dermocybe sanguinea. Mutat. Res. 269:1992;27-33.
4. Hattori M., Akao T., Kobashi K., Namba T. Cleavages of the O-and C-Glucosyl Bonds of Anthrone and 10,10′-Bianthrone Derivatives by Human Intestinal Bacteria. Pharmacology. 47:(suppl. 1):1993;125-133.
5. Mori H., Sugie S., Niwa K., Takahashi M., Kawai K. Induction of intestinal tumors in rats by chrysazin. Br. J. Cancer. 52:1985;781-783.
6. Mori H., Sugie S., Niwa K., Yoshimi N., Tanaka T., Hirono I. Carcinogenicity of Chrysazin in Large Intestine and Liver of Mice. Japanese Journal of Cancer Research. 77:1986;871-876.
7. Siegers C.P., von Hetzberg-Lottin E., Otte M., Schneider B. Anthranoid laxative abuse - a risk for colorectal cancer? Gut. 34:(8):1993;1099-1101.
8. Kune G.A. Laxative use not a risk for colorectal cancer: data from the Melbourne colorectal cancer study. Z. Gastroenterol. 1:1993;140-143.
9. Tikkanen L., Matsushima T., Natori S. Mutagenicity of anthraquinones in the Salmonella preincuabation test. Mutat. Res. 116:1983;297-304.
10. Bruggemann I.M., van der Hoeven J.C.M. Lack of activity of the bacterial mutagen emodin in HGPRT and SCE assay with V79 Chinese hamster cells. Mutat. Res. 138:1984;219-224.
11. Bösch R., Friederich U., Lutz W.K., Brocker E., Bachmann M., Schlatter C. Investigations on DNA binding in rat liver and in Salmonella and on mutagenicity in the Ames test by emodin, a natural anthraquinone. Mutat. Res. 188:1987;161-168.
12. Westendorf J., Marquardt H., Poginsky B., Dominiak M., Schmidt J., Marquardt H. Genotoxicity of naturally occuring hydroxyanthraquinones. Mutat. Res. 240:1990;1-12.
13. Krivobok S., Seigle-Murandi F., Steiman R., Marzin D.R., Betina V. Mutagenicity of substituted anthraquinones in the Ames/Salmonella microsome system. Mutat. Res. 279:(1):1992;1-8.
14. Hao N.J., Huang M.P., Lee H. Structure-activity relationships of anthraquinones as inhibitors of 7-ethoxycoumarin O-deethylase and mutagenicity of 2-amino-3-methylimidazo(4,5-f)quinoline. Mutat. Res. 328:1995;183-191.
15. Su H.Y., Cheng S.H., Chen C.C., Lee H. Emodin inhibits the mutagenicity and DNA adducts induced by 1-nitropyrene. Mutat. Res. 329:1995;205-212.
16. Morita H., Umeda H., Masuda T., Ueno Y. Cytotoxic and mutagenic effects of emodin on cultured mouse carcinoma FM3A cells. Mutat. Res. 204:1988;329-332.
17. Masuda T., Hairakawa K., Morooka N., Nakano S., Ueno Y. 2-Hydroxy-emodin, an active metabolite of emodin in the hepatic microsomes of rats. Mutat. Res. 149:1985;327-332.
18. Heidemann A., Miltenburger H.G., Mengs U. The genotoxicity status of senna. Pharmacol. 47:1993;178-186.
19. Brown J.P. A review of the genetic effects of the naturally occuring flavonoids, anthraquinones and related compounds. Mutat. Res. 75:1980;243-277.
20. Wölfle D., Westendorf J., Schmutte C., Dominiak M., Poginski B., Marquardt H. Genotoxicity, cell transformation and growth stimulation (promotion) in vitro induced by hydroxyanthraquinones. 7th Edn. Proc. Amer. Canc. Res. 30:1989;142.
21. Carballo M.A., D'Aquino M., Aranda E.I. Accion clastogenica de un compuesto antraguinonico en linfocitos humanos. Medicina (Buenos Aires). 41:1981;531-534.
22. Simi S., Morelli S., Gervasi P.G., Rainaldi G. Clastogenicity of anthraquinones in V79 and in three derived cell lines expressing P450 enzymes. Mutat. Res. 347:1995;151-156.
23. Swanbeck G. Interaction between deoxyribonucleic acid and some anthracene and anthraquinone derivatives. Biochem. Biophys. Acta. 123:1966;630-633.
24. Anderson R.D., Berger N.A. Mutagenicity and carcinogenicity of topoisomerase-interactive agents. Mutation Research. 309:1994;109-142.
25. Holm C., Stearns T., Bostein D. DNA topoisomerase II must act at mitosis to prevent nondisjunction and chromosomes breakage. Mol. Cell. Biol. 9:1989;159-168.
26. Downes C.S., Mullinger A.M., Johnson R.T. Inhibitors of topoisomerase II prevent chromatid separation in mammalian cells but do not prevent exit from mitosis. 7th Edn. Proc. Natl. Acad. Sci. USA. 88:1991;8895-8899.
27. Wang J.R., Caron P.R., Kim R.A. The role of DNA topoisomerases in recombination and genomic stability: a double-edged sword? Cell. 62:1990;403-406.
28. Gaulden M.E. Hypothesis: some mutagens directly alter specific chromosomal proteins (DNA topoisomerase II and peripheral proteins) to produce chromosome stickiness, which causes chromosome aberrations. Mutagenesis. 2:1987;357-365.
29. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA dammage in individual cells. Exp. Cell Res. 175:1988;184-191.
30. Stopper H., Eckert I., Schiffmann D., Spencer D.L., Caspary W.J. Is micronucleus induction by aneugens an early event leading to mutagenesis? Mutagenesis. 9:(5):1994;411-416.
31. Combes R.D., Stopper H., Caspary W.J. The use of the L5178Y mouse lymphoma cells to assess mutagenic, clastogenic and aneugenic activity of chemicals. Mutagenesis. 10:(5):1995;403-408.
32. Shibuya M.L., Ueno A.M., Vannais D.B., Craven P.A., Waldren C.A. Megabase pair deletions in mutant mammalian cells following exposure to amsacrine, an inhibitor of DNA topoisomerase II. Cancer Res. 54:1994;1092-1097.
33. McGregor D.B., Riach C., Cattanach P., Edwards I., Shepherd W., Caspary W.J. A comparison of mutagenic response of L5178Y mouse cells at the tk and hprt loci. Environm. Molec. Mutagen. 1995;. in press.
34. McGregor D.B., Edwards I., Wolf C.R., Forrester L.M., Caspary W.J. Endogenous xenobiotic enzyme levels in mammalian cells. Mutat. Res. 261:1991;29-39.
35. Marini J.C., Miller K.G., Englund P.T. Decatenation of kinetoplast DNA by topoisomerase. J. Biol. Chem. 255:1980;4976-4979.
36. Zwelling L.A., Minford J., Nichols M., Glazier R.I., Shackney S. Enhancement of intercalator-induced deoxyribonucleic acid scission and cytotoxicity in murine leukemia cells treated with 5-azacytidine. Biochem. Pharmacol. 33:(23):1984;3903-3906.
37. Kaufmann W.K., Boyer J.C., Estabrooks L.L., Wilson S.J. Inhibition of replicon initiation in human cells following stabilization of topoisomerase-DNA cleavable complexes. Mol. Cell. Biol. 11:(7):1991;3711-3718.
38. Dubrez L., Goldwasser F., Genne P., Pommier Y., Solary E. The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors. Leukemia. 9:(6):1995;1013-1024. Topo II.
39. Olive P.L., Banath J.P., Durand R.E. Detection of etoposide resistance by measuring DNA damage in individual Chinese hamster cells. J. Natl. Cancer Inst. 82:1990;779-783.
40. Olive P.L., Banath J.P. Detection of DNA double-strand breaks through the cell cycle after exposure to X-rays, bleomycin, etoposide and 1251dUrd. Int. J. Radiat. Biol. 64:1993;349-358.
41. Stopper H., Eckert I., Wagener P., Schulz W. Formation of micronuclei and inhibition of topoisomerase II in the comet-assay in mammalian cells with altered DNA-methylation. Recent Results Cancer Res. 1995;. in press.
42. McKelvey-Martin V.J., Green M.H.L., Schmezer P., Pool-Zobel B.L., De Meo M.P., Collins A. The single cell gel electrophoresis assay (comet assay): a European review. Mutat. Res. 288:1993;47-63.